BCMA board votes to appeal ruling on dissidentDr. Caroline Wang had won case over her treatment as a board member; petition launched to review appeal Generic drug maker suit against government reaches courtHearings start in the generic pharmaceutical industry's legal challenge of extended market monopolies for brand name drugs in the Federal Court of Canada. Katz CEO to lead NACDS Andrew Giancamilli, CEO of Katz Group North America and Snyder's Drug Stores, is the newly appointed chairman of the board of the NACDS, Alta. doctors looking to help shape ‘superboard’ Ruminations on ‘Good King Wenceslas’ Court slams BCMA board for treatment of dissident member Government-speak: Full of sound and fury, signifying nothing LETTER: Pharma needs to be more upfront about drug risks Jamieson Laboratories Unveils New Quality-Assurance Protocol Canada's largest manufacturer and distributor of advanced natural health products recently announced its commitment to a rigorous new set of quality-control benchmarks. Conflict-of-interest regulation bad for research Researchers may wonder if they can measure up to application and reporting standards. They may conclude they can’t First Previous 201 202 203 204 Next Last
